ASIRI SURGICAL HOSPITAL PLC |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 11.5 LKR | +0.88% |
|
+1.77% | -10.85% |
| Sales 2022 | 5.84B 19.76M 26.97M | Sales 2023 | 5.63B 19.07M 26.03M | Capitalization | 6.61B 22.36M 30.52M |
|---|---|---|---|---|---|
| Net income 2022 | 1.18B 4.01M 5.47M | Net income 2023 | 555M 1.88M 2.56M | EV / Sales 2022 | 1.89 x |
| Net Debt 2022 | 3.12B 10.57M 14.43M | Net Debt 2023 | 3.87B 13.1M 17.88M | EV / Sales 2023 | 1.86 x |
| P/E ratio 2022 |
6.69
x | P/E ratio 2023 |
11.9
x | Employees | - |
| Yield 2022 |
14% | Yield 2023 |
-
| Free-Float | 6.67% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | +0.88% | ||
| 1 week | +1.77% | ||
| Current month | -0.86% | ||
| 3 months | -4.17% | ||
| 6 months | -11.54% | ||
| Current year | -10.85% |
1 week
11.20
11.80
1 month
11.1011.80
Current year
10.5012.90
1 year
10.5013.70
3 years
10.5025.50
5 years
8.5025.50
10 years
8.5025.50
| Managers | Title | Age | Since |
|---|---|---|---|
K. Karunaratne
CEO | Chief Executive Officer | - | 06-05-31 |
| Director of Finance/CFO | - | - | |
Aruni Munasinghe
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
K. Karunaratne
CEO | Chief Executive Officer | - | 06-05-31 |
| Director/Board Member | - | 04-12-31 | |
| Director/Board Member | - | 08-02-29 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-26 | 11.5 | +0.88% | 9,368 |
| 24-04-25 | 11.4 | -0.87% | 14,213 |
| 24-04-24 | 11.5 | 0.00% | 10,109 |
| 24-04-22 | 11.5 | +1.77% | 13,102 |
| 24-04-19 | 11.3 | -0.88% | 22,300 |
End-of-day quote Colombo S.E., April 25, 2024
More quotes
Asiri Surgical Hospital PLC is a Sri Lanka-based healthcare provider. The Company provides a complete range of services through technology. The Company operates through three segments: Pre care, Post care and Pharmaceutical. The Pre care segment is engaged in the outpatient department (OPD) lab investigation services. The Post care segment provides all inpatient department (IPD), including inpatient drugs and lab investigation. The Pharmaceutical segment includes OPD pharmacy. It has various centers, including Asiri-Heart Centre; Brain and Spine Centre; Stroke Unit; Asiri AOI Cancer Centre; Cosmetic Centre; Urology Unit; Blood Cancer & Bone Marrow Transplant Centre; Interventional Radiology; Vaccination Clinic, and Kidney Transplant Unit. Its health and wellness services provide wellness centers, breast care center, well womenâs clinic, audiology unit, sleep study, psychology, elderly care service and Asiri mindfulness center.
| 1st Jan change | Capi. | |
|---|---|---|
| -10.85% | 20.54M | |
| -20.16% | 16.21B | |
| +4.50% | 12.44B | |
| +3.98% | 11.58B | |
| +9.72% | 10.79B | |
| +23.61% | 8.26B | |
| -2.19% | 7.68B | |
| +20.75% | 7.2B | |
| +4.49% | 6.67B | |
| +50.89% | 4.66B |
- Stock Market
- Equities
- AMSL.N0000 Stock
